<DOC>
	<DOC>NCT00943397</DOC>
	<brief_summary>Patients were treated with either montelukast 4 mg oral granules or usual care. Patients who completed Protocol MK0476-176-01 (NCT00943683) had the option to enroll in this study. Additionally, patients with asthma who were 6 to 11 months of age and who had not participated in Protocol MK0476-176-01, could also enroll.</brief_summary>
	<brief_title>Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patient successfully completed visit 5 of MK0476 Protocol 176 (NCT00943683) OR: Patient is in good, stable health Patient has been fed solid foods for at least 1 month Patients had at least 3 episodes of asthma or asthmalike symptoms, all occurring after 8 weeks of age; at least one within 6 months of the Prestudy Visit Patients had to be in need of a controller therapy according to criteria established in the Global Initiative for Asthma (GINA) guidelines Patient was hospitalized at the start of the study or had any major surgery 4 weeks prior Patient had an allergy to apples or applesauce</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>